[1]
Aisha Alyassi, “GLP-1 RECEPTOR AGONISTS AS A BREAKTHROUGH THERAPY FOR OBESITY AND METABOLIC SYNDROME: A SYSTEMATIC REVIEW OF EFFICACY AND LONG-TERM OUTCOMES”, J Popl Ther Clin Pharmacol, vol. 31, no. 11, pp. 1915–1925, Dec. 2024, doi: 10.53555/6tdd8g65.